Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
How Zealand CSO aims to create a 'generational biotech leader'
Zealand is gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain may hold the key to long-term success.
James Waldron
Dec 12, 2025 1:00pm
Lilly's obesity triple threat tops phase 3 efficacy forecasts
Dec 11, 2025 8:15am
Pfizer signs $1.9B pact for Fosun unit's GLP-1 drug
Dec 9, 2025 8:00am
Lilly looks to become innovation ‘backbone,’ exec says
Dec 8, 2025 12:05pm
Wave, Structure stocks double on obesity data readouts
Dec 8, 2025 10:50am
Ascletis reports 7.7% weight loss for oral GLP-1 contender
Dec 8, 2025 8:35am
